DalsnaFinance

SITC Announces EU Immuno-oncology Drug Development Summit - Bringing the European IO Community Together to Foster the Next Wave of IO Therapeutics

Markets PR Newswire By PR Newswire 22 Jul 2026 14:00 1 min read
SITC Announces EU Immuno-oncology Drug Development Summit - Bringing the European IO Community Together to Foster the Next Wave of IO Therapeutics

Keynote Address featuring Dr. E. John Wherry – "Intersection of IO and Autoimmunity" MILWAUKEE, July 22, 2026 /PRNewswire/ -- The Society for Immunotherapy of Cancer (SITC) is proud to announce the upcoming EU Immuno-oncology Drug Development Summit, taking place in Lausanne, Switzerland...

Keynote Address featuring Dr. E. John Wherry – "Intersection of IO and Autoimmunity" MILWAUKEE, July 22, 2026 /PRNewswire/ -- The Society for Immunotherapy of Cancer (SITC) is proud to announce the upcoming EU Immuno-oncology Drug Development Summit, taking place in Lausanne, Switzerland...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.